期刊
TRENDS IN MOLECULAR MEDICINE
卷 27, 期 7, 页码 643-659出版社
CELL PRESS
DOI: 10.1016/j.molmed.2021.04.005
关键词
-
资金
- Edward P. Evans Foundation
- Henry and Marilyn Taub Foundation for MDS Research
- National Institutes of Health [R01 CA242020, R01 HL128239, R01 CA251138]
RNA splicing is a process where non-protein coding sequences are removed from RNA to produce mature protein-coding mRNA. Genetic alterations and changes in splicing factors can lead to various human genetic diseases and cancer. Therapies based on oligonucleotides and small molecules targeting splicing factors are currently being developed for different genetic disorders and cancer.
RNA splicing is the enzymatic process by which non-protein coding sequences are removed from RNA to produce mature protein-coding mRNA. Splicing is thereby a major mediator of proteome diversity as well as a dynamic regulator of gene expression. Genetic alterations disrupting splicing of individual genes or altering the function of splicing factors contribute to a wide range of human genetic diseases as well as cancer. These observations have resulted in the development of therapies based on oligonucleotides that bind to RNA sequences and modulate splicing for therapeutic benefit. In parallel, small molecules that bind to splicing factors to alter their function or modify RNA processing of individual transcripts are being pursued for monogenic disorders as well as for cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据